Showing results (81-90 of 90) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2022
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patientsGisella Guerrera, Alessandra Mandelli, Annamaria Finardi, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 28, 2019
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?Marinella Clerico, Stefania Federica De Mercanti, Alessio Signori, et al.Frontiers in Neurology|January 2, 2023
Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapiesEli Hatchwell, Edward B Smith, Shapour Jalilzadeh, et al.Journal of the Neurological Sciences|March 26, 2021
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian studyStefania Federica De Mercanti, Alessio Signori, Cinzia Cordioli, et al.Genes|December 23, 2022
A Whole-Genome Sequencing Study Implicates GRAMD1B in Multiple Sclerosis SusceptibilityFederica Esposito, Ana Maria Osiceanu, Melissa Sorosina, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 31, 2013
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study groupAntonio Bertolotto, Marco Capobianco, Maria Pia Amato, et al.Neurology|August 9, 2013
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patientsNicholas Schwab, Tilman Schneider-Hohendorf, Vilmos Posevitz, et al.Journal of Neurology|October 25, 2017
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter studySara Mariotto, Sergio Ferrari, Salvatore Monaco, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 30, 2022
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosisDoriana Landi, Francesca Bovis, Alfonso Grimaldi, et al.Nature|August 12, 2011
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis, , Stephen Sawcer, et al.Pageof 9